PMID- 9973316 OWN - NLM STAT- MEDLINE DCOM- 19990331 LR - 20190516 IS - 0892-6638 (Print) IS - 0892-6638 (Linking) VI - 13 IP - 2 DP - 1999 Feb TI - Oxygen tension modulates beta-globin switching in embryoid bodies. PG - 285-95 AB - Little is known about the factors influencing the hemoglobin switch in vertebrates during development. Inasmuch as the mammalian conceptus is exposed to changing oxygen tensions in utero, we examined the effect of different oxygen concentrations on beta-globin switching. We used an in vitro model of mouse embryogenesis based on the differentiation of blastocyst-derived embryonic stem cells to embryoid bodies (EBs). Cultivation of EBs at increasing oxygen concentrations (starting at 1% O2) did not influence the temporal expression pattern of embryonic (betaH1) globin compared to the normoxic controls (20% O2). In contrast, when compared to normoxically grown EBs, expression of fetal/adult (betamaj) globin in EBs cultured at varying oxygen concentrations was delayed by about 2 days and persisted throughout differentiation. Quantitation of hemoglobin in EBs using a 2,7-diaminofluorene-based colorimetric assay revealed the appearence of hemoglobin in two waves, an early and a late one. This observation was verified by spectrophotometric analysis of hemoglobin within single EBs. These two waves might reflect the switch of erythropoiesis from yolk sac to fetal liver. Reduced oxygenation is known to activate the hypoxia-inducible factor-1 (HIF-1), which in turn specifically induces expression of a variety of genes among them erythropoietin (EPO). Although EBs increased EPO expression upon hypoxic exposure, the altered beta-globin appearance was not related to EPO levels as determined in EBs overexpressing EPO. Since mRNA from both mouse HIF-1alpha isoforms was detected in all EBs tested at different differentiation stages, we propose that HIF-1 modulates beta-globin expression during development. FAU - Bichet, S AU - Bichet S AD - Institute of Physiology, University of Zurich-Irchel, 8057 Zurich, Switzerland. FAU - Wenger, R H AU - Wenger RH FAU - Camenisch, G AU - Camenisch G FAU - Rolfs, A AU - Rolfs A FAU - Ehleben, W AU - Ehleben W FAU - Porwol, T AU - Porwol T FAU - Acker, H AU - Acker H FAU - Fandrey, J AU - Fandrey J FAU - Bauer, C AU - Bauer C FAU - Gassmann, M AU - Gassmann M LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - FASEB J JT - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JID - 8804484 RN - 0 (DNA-Binding Proteins) RN - 0 (Hif1a protein, mouse) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Nuclear Proteins) RN - 0 (Transcription Factors) RN - 9004-22-2 (Globins) RN - S88TT14065 (Oxygen) SB - IM MH - Aerobiosis MH - Anaerobiosis MH - Animals MH - DNA-Binding Proteins/genetics MH - Embryonic and Fetal Development/drug effects/*genetics MH - *Gene Expression Regulation, Developmental/drug effects MH - Globins/*genetics MH - Hypoxia-Inducible Factor 1 MH - Hypoxia-Inducible Factor 1, alpha Subunit MH - Mice MH - Nuclear Proteins/genetics MH - Oxygen/*metabolism/pharmacology MH - *Transcription Factors EDAT- 1999/02/11 00:00 MHDA- 1999/02/11 00:01 CRDT- 1999/02/11 00:00 PHST- 1999/02/11 00:00 [pubmed] PHST- 1999/02/11 00:01 [medline] PHST- 1999/02/11 00:00 [entrez] AID - 10.1096/fasebj.13.2.285 [doi] PST - ppublish SO - FASEB J. 1999 Feb;13(2):285-95. doi: 10.1096/fasebj.13.2.285.